RH Pharma Consulting Ltd 12682575 false 2023-07-01 2024-06-30 2024-06-30 The principal activity of the company is Research & experimental development on biotechnology Digita Accounts Production Advanced 6.30.9574.0 true 12682575 2023-07-01 2024-06-30 12682575 2024-06-30 12682575 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 12682575 bus:Micro-entities 2023-07-01 2024-06-30 12682575 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 12682575 bus:FilletedAccounts 2023-07-01 2024-06-30 12682575 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 12682575 bus:RegisteredOffice 2023-07-01 2024-06-30 12682575 bus:Director1 2023-07-01 2024-06-30 12682575 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 12682575 countries:EnglandWales 2023-07-01 2024-06-30 12682575 2022-07-01 2023-06-30 12682575 2023-06-30 12682575 core:CurrentFinancialInstruments core:WithinOneYear 2023-06-30 iso4217:GBP xbrli:pure

Registration number: 12682575

RH Pharma Consulting Ltd

Unaudited Filleted Financial Statements

for the Year Ended 30 June 2024

 

RH Pharma Consulting Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

RH Pharma Consulting Ltd

Company Information

Director

Dr Richard Hamlyn

Registered office

107 High Street
Sutton, Ely
Cambridgeshire
CB6 2NW

Accountants

Mrs Victoria Anne Cooper
Red Shoes Accounting Services
Unit 7 E-Space North
181 Wisbech Road
Littleport
Cambridgeshire
CB6 1RA

 

RH Pharma Consulting Ltd

(Registration number: 12682575)
Balance Sheet as at 30 June 2024

2024
£

2023
£

Fixed assets

1,681

2,913

Current assets

6,577

12,083

Prepayments and accrued income

-

1,800

Creditors: Amounts falling due within one year

(313)

(1,673)

Net current assets

6,264

12,210

Total assets less current liabilities

7,945

15,123

Accruals and deferred income

(600)

(570)

 

7,345

14,553

Capital and reserves

7,345

14,553

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
107 High Street
Sutton, Ely
Cambridgeshire
CB6 2NW

These financial statements were authorised for issue by the director on 28 November 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

For the financial year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

RH Pharma Consulting Ltd

(Registration number: 12682575)
Balance Sheet as at 30 June 2024

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 28 November 2024
 

Dr Richard Hamlyn
Director